Single-Use Bioprocess Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
Technological Advancements and Rising Biopharmaceutical Demand Drive Market Expansion
The global single-use bioprocess systems market is projected to witness substantial growth in the coming years, according to a recent study by Fairfield Market Research. The market reached a valuation of US$ 6.6 billion in 2024, it is anticipated to reach US$ 25 billion by 2031.
Key Market Drivers
The adoption of single-use systems (SUS) is viewed as an economically viable strategy for enhancing productivity and process efficiency in biomanufacturing. The market benefits from sustainable disposables offered by numerous vendors, which outperform traditional stainless steel bioreactors.
Technological Adoption Fuels Growth
Manufacturers are investing heavily in research and development to produce innovative single-use bioprocessing systems, shifting focus from conventional steel bioreactors to disposable alternatives. New technologies promise higher adoption rates, driven by benefits such as reduced cleaning requirements, energy efficiency, and minimized cross-contamination risks.
Market Challenges and Opportunities
Despite the market's growth trajectory, rising consumable costs and concerns about industrial pollution pose challenges. However, increased investments in environmentally friendly product development and the expanding biopharmaceutical industry offer opportunities for sustained growth.
Regional Insights
• United States: The U.S. remains a lucrative market, driven by substantial R&D funding and a robust biopharmaceutical manufacturing sector.
• China: With a growing biopharmaceutical industry, China showcases significant demand for single-use bioprocess systems, driven by the adoption of cutting-edge technologies and expansion in mAb development.
• Germany: As an established player in Europe, Germany sees high demand for single-use bioprocess systems, particularly in complex antibody production and commercial biomanufacturing.
Category-wise Insights
• Bioreactors: Major drivers of market growth, with increasing usage across regions due to advantages over conventional bioreactors.
• Applications: GMP and commercial production dominate the market, fueled by demand for drug discovery, monoclonal antibodies, and cell culture.
• End Users: Biopharmaceutical companies account for the largest adoption, driven by the need for safe and cost-effective biologics production.
Competitive Analysis
Leading manufacturers are leveraging mergers, acquisitions, and collaborations to strengthen market presence and expand product lines globally.
Key Companies Profiled
• Thermo Fisher Scientific
• Sartorius Stedim Biotech
• Danaher Corporation
• Merck KGaA (Millipore)
• Corning
• Avantor
• CESCO Bioengineering Co. Ltd.
• PBS Biotech, Inc.
• Distek, Inc.
• Eppendorf AG
• Celltainer Biotech B.V.
• Getinge (Applikon Biotechnology)
• Cellexus Ltd.
• Parker Hannifin Corp
• Mettler-Toledo International, Inc.
Single-Use Bioprocess Systems Industry Research Segmentation
By Component:
• Bioreactors
Cell Culture Bioreactors
Fermentation Bioreactors
• Mixers
• Bioprocess Containers
• Transfer and Storage Bags
• Sampling Systems
• Filtration Systems
• Chromatography Columns
• Probes & Sensors
• Tubing Assemblies
• Connectors & Clamps
• Filling Systems
By Application:
• Research & Development (R&D)
• GMP and Commercial Production
By End User:
• Biopharmaceutical Companies
• Contract Research Organizations
• Contract Manufacturing Organizations
• Research Institutes
By Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.